Articles

In July 2002 a large, randomized control trial called the Women’s Health Initiative was stopped three years early with the conclusion that Estrogen plus Progestin (E+P) is, on balance, not an effective preventative medication for healthy menopausal women. The results of this trial have surprised both doctors and the general public, because they have shown that E+P does not prevent heart disease and causes breast cancer (1). We believe there are several changes in concepts about menopausal hormone therapy that are important for breast cancer survivors.

Women’s bone health is closely related to the ovarian hormones,

QUESTION

Acute COVID-19 Illness and Menstrual Cycles

It is difficult living with

Science today recognizes that most new knowledge is never shared. New studies are finally funded, eventually the study is complete, the research is written, reviewed by other scientists and eventually published—all after great effort. But the people who participated in that research and others world-wide for whom the data are relevant, never learn about it. Although rarely there is media notice, often the publication just sits there.

by Drs. Jerilynn C. Prior & Azita Goshtasebi

Use of “The Pill” prevents bone growth in teenaged women. New evidence resulting from combining two-year-long studies in almost 900 adolescent women using Combined Hormonal Contraceptives (CHC) women, showed negative bone changes.

Really?

Dr. Jerilynn Prior has written an article for the period tracking app, Clue.

Frequently Asked Questions about Anovulatory